Traitement médical de l’hypoactivité vésicale

Abrams P, Cardozo L, Fall M, et al. (2002) The standardisation of terminology of lower urinary tract function: report for the standardisation sub-committee of the International Continence Society. Neurourol Urodyn 21: 167–178 Haab F, Amarenco G, Coloby P, et al. (2006) Terminologie des troubles fonctionnels du bas appareil urinaire, adaptation française de la terminologie de l’International Continence Society. Pel Perineol 1: 196–206 Abrams P, Andersson KE, Buccafusco JJ, et al. (2006) Muscarinic receptors: their distribution and function in body systems, and the implications for treating overactive bladder. Br J Pharmacol 148: 565–578 Andersson KE, Arner A (2003) Urinary bladder contraction and relaxation: physiology and pathophysiology. Physiol Rev 84: 935–986 Harris D, Marsh KA, Birmingham AT, Hill SJ (1995) Expression of muscarinic M3-receptors coupled to inositol phospholipidis hydrolysis in human detrusor cultured smooth muscle cells. J Urol 154: 1241 Andersson KE (2002) Bladder activation: afferent mechanisms. Urology 59(S5A): 43–50 Finkbeiner AE (1985) Is betanechol chloride clinically effective in promoting bladder emptying: a literature review. J Urol 134: 443–449 Taylor P (2006) Anticholinesterase agents. In: Brunton LL, Lazo JS, Parker KL (eds.), Goodman and Gilman’s the pharmacological basis of therapeutics, 11th ed, Chapter 8: McGraw-Hill Companies, Inc Taylor P (1985) Cholinergic agonists. In Pharmacological basis of therapeutics. Gilman AG, Goodman LS, Gilman A Ed. 7th Ed Mac Millan, New York King JA, Huddart H, Staff WG (1998) Effect of choline ester analogues, noradrenaline and nifedipine on normal and hypertrophied human urinary bladder detrusor muscle. Gen Pharmac 30: 131–136 Diokno AC, Lapides J (1977) Action of oral and parenteral betanechol on decompensed bladder. Urology 10: 23–24 Barrett DM (1981) The effect of oral bethanechol chloride on voiding in female patients with excessive residual urine: a randomized double-blind study. J Urol 126: 640–642 Burger DH, Kappetein AP, Boutkan H, Breslau PJ (1997) Prevention of urinary retention after general surgery: a controlled trial of carbachol/diazepam versus alfuzosine. J Am Coll Surg 185: 234–236 Gottesman L, Milsom JW, Mazier WP (1989) The use of anxiolytic and parasympathomimetic agents in the treatment of postoperative urinary retention following anorectal surgery. A prospective, randomized, double-blind study. Dis Colon Rectum 32: 867–870 Riedl CR, Daha LK, Knoll M, Pfluger H (2002) Bethanechol in the restitution of the acontractile detrusor: a prospective, randomized, double blind, placebo-controlled study. Neurourol Urodyn 21: 376 Hindley RG, Brierly RD, Thomas PJ (2004) Prostaglandin E2 and bethanechol in combination for treating detrusor underactivity. BJU Int 93: 89–92 Yamanishi T, Yasuda K, Kamai T, et al. (2004) Combination of a cholinergic drug and an α-blocker is more effective than monotherapy for the treatment of voiding difficulty in patients with underactive detrusor. Int J Urol 11: 88–96 Madeiro AP, Rufino AC, Sartori MGF, et al. (2006) The effects of betanechol and cisapride on urodynamic parameters in patients undergoing radical hysterectomy for cervical cancer. A randomized, double-blind, placebo-controlled study. Int Urogynecol 17: 248–252 Kemp B, Kitschke HJ, Goetz M, Heyl W (1997) Prophylaxis and treatment of bladder dysfunction after Wertheim-Meigs operation: the positive effect of early postoperative detrusor stimulation using the cholinergic drug betanecholchloride. Int Urogynecol J Pelvic Floor Dysfunct 8: 138–141 Fleming AR (1957) The use of urecholine in the prevention of postpartum urinary retention: final report. Amer J Obst Gynec 74: 569 Sonda LP, Gershon C, Diokno A, Lapides J (1979) Further observations on the cystometric and uroflowmetric effects of betanechol chloride on the human bladder. J Urol 122: 775 McConnell J, Benson GS, Wood JG (1982) Autonomic innervations of the innervations of the urogenital system: adrenergic and cholinergic elements. Brain Res Bull 9: 679–694 Maggi CA, Meli A, Santicioli P (1987) Neuroeffector mechanisms in the voiding cycle of the guinea-pig urinary bladder. J Auton Pharm 7: 295–308 Nagabukuro H, Okanishi S, Imai S, et al. (2004) Effects of TAK-802, a novel acetylcholinesterase inhibitor, on distension-induced rythmic bladder contractions in rats and guinea pigs. Eur J Pharmacol 485: 299–305 Bougas DA, Mitsogiannis IC, Mitropoulos DN, et al. (2004) Clinical efficacy of distigmine bromide in the treatment of patients with underactive detrusor. Int Uro Nephrol 36: 507–512 Tanaka Y, Masumori N, Itoh N, et al. (2001) Symptomatic and urodynamic improvement by oral distigmine bromide in poor voiders after transurethral resection of the prostate. Urology 57: 270–274 Shah PJ, Abrams PH, Choa RG et al. (1983) Distigmine bromide and post-prostatectomy voiding. Br J Urol 55: 229–232 Savona-Ventura C, Grech ES, Saliba I (1991) Pharmacological measures to prevent post-operative urinary retention; a prospective randomized study. Eur J Obstet Gynecol Reprod Biol 41: 225–229 Tonini M, Mesori E, Franceschetti GP, et al. (1994) Characterization of the 5-HT receptor potentiating neuromuscular cholinergic transmission in strips of human isolated detrusor muscle. Br J Pharmacol 113: 1–2 Hanson P, Soler JM (1989) Effet du cisapride sur les vessies neurologiques. Acta Belg Med Phys 12: 81–88 Carone R, Vercelli D, Bertapelle P (1993) Effects of cisapride on anorectal and vesicourethral function in spinal cord injured patients. Paraplegia, pp 125–127 Wyndaele JJ, Van Kerrebroeck P (1995) The effects of 4 weeks tretment with cisapride on cystometric parameters in spinal cord injury patients. A double-blind, placebo controlled study. Paraplegia, pp 625–627 Steele AC, Walsh P, Bentley M, et al. (2001) A randomized, double-blind placebo-controlled trial of the effects of the 5-hydroxytriptamine (4) agonist cisapride on the female urinary bladder. Am J Obstet Gynecol 185: 62–64 Food and Drug Administration (2000) FDA Talk paper Too-14. US Department of Health and Human Services; March Yoshida M, Inadome A, Yono M, et al. (2000) Effects of prostaglandin E2 receptors antagonist in overactive bladder in the chronic spinal rats. Neurourol Urodyn 19: 407–408 Ishizuka O, Mattiasson A, Andersson KE (1995) Prostaglandin E2-induced bladder hyperactivity in normal, conscious rats: involvement of tachykinins? J Urol 153: 2034–2038 Wagner G, Husslein P, Enzelsberger H (1985) Is prostaglandin E2 really of therapeutic value for postoperative urinary retention? Results of a prospectively randomized double-blind study. Am J Obstet Gynecol 151: 375–379 Bergman A, Mushkat Y, Gordon D, David MP (1992) Prostaglandin for enhancing bladder function after vaginal surgery. Does it work? J Reprod Med 37: 320–322 Bergman A, Mushkat Y, Gordon D, David MP (1993) Prostaglandin prophylaxis and bladder function after vaginal hysterectomy: a prospective randomized study. Br J Obstet Gynaecol 100: 69–72 Grignaffini A, Bazzani F, Bertoli P, et al. (1998) Intravesicular prostaglandin E2 for the prophylaxis of urinary retention after colpohysterectomy. J Int Med Res 26: 87–92 Wein AJ, Raezer DM, Alsobrook WL (1980) Failure of the betanechol supersensitivity test to predict improved voiding after subcutaneous betanechol administration. J Urol 123: 202–203 Riedl CR, Stephen RL, Daha LK, et al. (2000) Electromotive administration of intravesical betanechol and the clinical impact on acontractile detrusor management: introduction of a new test. J Urol 164: 2108–2111 De Wachter S, Van Meel TD, Wyndaele JJ (2003) Study of the afferent nervous system and its evaluation in women with impaired detrusor contractility treated with betanechol. Urology 62: 54–58 Ek A, Andersson KE, Ulmsten U (1978) The effects of norephedrine and betanechol on the human urethral closure pressure profile. Scand J Urol Nephrol 12: 97 Yamanishi T, Chapple CR, Yasuda K, et al. (2002) The role of M2 muscarinic receptor subtypes mediating contraction of the circular and longitudinal smooth muscle of the pig proximal urethral. J Urol 168: 308–314 Gillepsie JI, Harvey IJ, Drake MJ (2003) Agonist and nerve induced phasic activity in the isolated whole bladder of the guinea pig. Evidence for two types of bladder activity. Exp physiol 88: 343–357 Gillepsie JI (2004) Modulation of autonomous contractile activity in the isolated whole bladder of the guinea pig. BJU Int 93: 393–400 Fry CH, Ikeda Y, Harvey R, et al. (2004) Control of bladder function by peripheral nerves: avenues for novel drug targets. Urology 63(Suppl 3A): 24–31 Guyatt GH, Sacket DL, Sinclair JC, et al., for the Evidence-Based Medicine Working Group. IX (1995) A method for grading health care recommendations. JAMA 22: 1800–1804